

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | COPI coating of Golgi vesicle (GO:0048205) | 9.48140700 |
| 2 | Golgi transport vesicle coating (GO:0048200) | 9.48140700 |
| 3 | type B pancreatic cell development (GO:0003323) | 8.42449124 |
| 4 | glandular epithelial cell development (GO:0002068) | 7.29305931 |
| 5 | actin-myosin filament sliding (GO:0033275) | 6.98638148 |
| 6 | muscle filament sliding (GO:0030049) | 6.98638148 |
| 7 | endocrine pancreas development (GO:0031018) | 6.85652410 |
| 8 | protein maturation by protein folding (GO:0022417) | 6.75321147 |
| 9 | skeletal muscle contraction (GO:0003009) | 6.01697549 |
| 10 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 5.96810076 |
| 11 | positive regulation of glycolytic process (GO:0045821) | 5.96657790 |
| 12 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 5.96569188 |
| 13 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 5.86079845 |
| 14 | actin-mediated cell contraction (GO:0070252) | 5.74481194 |
| 15 | peptide hormone processing (GO:0016486) | 5.73017185 |
| 16 | glandular epithelial cell differentiation (GO:0002067) | 5.71539884 |
| 17 | positive regulation of nuclease activity (GO:0032075) | 5.69649839 |
| 18 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 5.68880477 |
| 19 | COPII vesicle coating (GO:0048208) | 5.64717284 |
| 20 | columnar/cuboidal epithelial cell development (GO:0002066) | 5.43258014 |
| 21 | response to muscle activity (GO:0014850) | 5.39280651 |
| 22 | plasma membrane repair (GO:0001778) | 5.36893587 |
| 23 | exocrine pancreas development (GO:0031017) | 5.29411738 |
| 24 | regulation of nuclease activity (GO:0032069) | 5.18268619 |
| 25 | myofibril assembly (GO:0030239) | 5.17442623 |
| 26 | protein retention in ER lumen (GO:0006621) | 5.15784510 |
| 27 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 5.14775504 |
| 28 | L-alpha-amino acid transmembrane transport (GO:1902475) | 5.10187362 |
| 29 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 5.06906661 |
| 30 | fatty acid homeostasis (GO:0055089) | 5.05198019 |
| 31 | negative regulation of gluconeogenesis (GO:0045721) | 5.00745243 |
| 32 | regulation of skeletal muscle contraction (GO:0014819) | 4.97382468 |
| 33 | endoplasmic reticulum unfolded protein response (GO:0030968) | 4.88485745 |
| 34 | fructose metabolic process (GO:0006000) | 4.83143815 |
| 35 | regulation of hexokinase activity (GO:1903299) | 4.74693887 |
| 36 | regulation of glucokinase activity (GO:0033131) | 4.74693887 |
| 37 | cellular response to unfolded protein (GO:0034620) | 4.71664797 |
| 38 | cellular response to vitamin D (GO:0071305) | 4.59789916 |
| 39 | ER-nucleus signaling pathway (GO:0006984) | 4.58823792 |
| 40 | vesicle coating (GO:0006901) | 4.58262792 |
| 41 | cellular response to topologically incorrect protein (GO:0035967) | 4.47804004 |
| 42 | positive regulation of insulin secretion (GO:0032024) | 4.34706502 |
| 43 | sarcomere organization (GO:0045214) | 4.29990435 |
| 44 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 4.26465309 |
| 45 | negative regulation of protein oligomerization (GO:0032460) | 4.26360451 |
| 46 | positive regulation of glycogen biosynthetic process (GO:0045725) | 4.26303358 |
| 47 | regulation of oxidative phosphorylation (GO:0002082) | 4.21898804 |
| 48 | actin filament-based movement (GO:0030048) | 4.19708955 |
| 49 | negative regulation of norepinephrine secretion (GO:0010700) | 4.16780002 |
| 50 | negative regulation of acute inflammatory response (GO:0002674) | 4.11355418 |
| 51 | regulation of insulin secretion (GO:0050796) | 4.09703117 |
| 52 | striated muscle contraction (GO:0006941) | 4.04807666 |
| 53 | glycogen catabolic process (GO:0005980) | 3.99048417 |
| 54 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.97489087 |
| 55 | regulation of relaxation of muscle (GO:1901077) | 3.97037403 |
| 56 | positive regulation of respiratory burst (GO:0060267) | 3.97036677 |
| 57 | cerebellar Purkinje cell layer development (GO:0021680) | 3.96603928 |
| 58 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 3.95465651 |
| 59 | response to hepatocyte growth factor (GO:0035728) | 3.95465651 |
| 60 | macroautophagy (GO:0016236) | 3.87698998 |
| 61 | * insulin secretion (GO:0030073) | 3.82596954 |
| 62 | muscle cell cellular homeostasis (GO:0046716) | 3.81672073 |
| 63 | intestinal cholesterol absorption (GO:0030299) | 3.79654950 |
| 64 | lactate metabolic process (GO:0006089) | 3.78513672 |
| 65 | response to endoplasmic reticulum stress (GO:0034976) | 3.76006950 |
| 66 | epithelial cell fate commitment (GO:0072148) | 3.75411028 |
| 67 | intestinal absorption (GO:0050892) | 3.73356632 |
| 68 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.73286096 |
| 69 | astrocyte differentiation (GO:0048708) | 3.71131071 |
| 70 | glucan catabolic process (GO:0009251) | 3.69872272 |
| 71 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.68868459 |
| 72 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.68437056 |
| 73 | regulation of peptide hormone secretion (GO:0090276) | 3.68034852 |
| 74 | positive regulation of glycogen metabolic process (GO:0070875) | 3.67781193 |
| 75 | 4-hydroxyproline metabolic process (GO:0019471) | 3.64691593 |
| 76 | response to ischemia (GO:0002931) | 3.63472887 |
| 77 | positive regulation of hormone biosynthetic process (GO:0046886) | 3.62793507 |
| 78 | chemosensory behavior (GO:0007635) | 3.62678997 |
| 79 | regulation of peptide secretion (GO:0002791) | 3.61926470 |
| 80 | glucan biosynthetic process (GO:0009250) | 3.61257083 |
| 81 | glycogen biosynthetic process (GO:0005978) | 3.61257083 |
| 82 | negative regulation of catecholamine secretion (GO:0033604) | 3.58702267 |
| 83 | creatine metabolic process (GO:0006600) | 3.58116362 |
| 84 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 3.56241716 |
| 85 | response to unfolded protein (GO:0006986) | 3.55576745 |
| 86 | negative regulation of insulin secretion (GO:0046676) | 3.52071150 |
| 87 | skeletal muscle fiber development (GO:0048741) | 3.51647259 |
| 88 | membrane repolarization during action potential (GO:0086011) | 3.50913250 |
| 89 | detection of calcium ion (GO:0005513) | 3.50783276 |
| 90 | protein targeting to Golgi (GO:0000042) | 3.50187039 |
| 91 | glycogen metabolic process (GO:0005977) | 3.50041415 |
| 92 | regulation of glucocorticoid metabolic process (GO:0031943) | 3.48147923 |
| 93 | positive regulation of peptide hormone secretion (GO:0090277) | 3.46530946 |
| 94 | skeletal muscle adaptation (GO:0043501) | 3.43664212 |
| 95 | sequestering of metal ion (GO:0051238) | 3.43424236 |
| 96 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 3.43106023 |
| 97 | muscle cell fate commitment (GO:0042693) | 3.42559119 |
| 98 | cellular glucan metabolic process (GO:0006073) | 3.41619086 |
| 99 | glucan metabolic process (GO:0044042) | 3.41619086 |
| 100 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.40935581 |
| 101 | intra-Golgi vesicle-mediated transport (GO:0006891) | 3.40482560 |
| 102 | cellular polysaccharide catabolic process (GO:0044247) | 3.40473679 |
| 103 | muscle contraction (GO:0006936) | 3.39984233 |
| 104 | ER overload response (GO:0006983) | 3.39895094 |
| 105 | response to topologically incorrect protein (GO:0035966) | 3.39874358 |
| 106 | positive regulation of histone deacetylation (GO:0031065) | 3.38485573 |
| 107 | Golgi organization (GO:0007030) | 3.38002242 |
| 108 | positive regulation of peptide secretion (GO:0002793) | 3.35961273 |
| 109 | regulation of energy homeostasis (GO:2000505) | 3.35777782 |
| 110 | negative regulation of glycogen biosynthetic process (GO:0045719) | 3.32242551 |
| 111 | peptidyl-asparagine modification (GO:0018196) | 3.31335689 |
| 112 | actomyosin structure organization (GO:0031032) | 3.31216070 |
| 113 | protein N-linked glycosylation via asparagine (GO:0018279) | 3.30424132 |
| 114 | inner ear receptor cell development (GO:0060119) | 3.23776462 |
| 115 | cellular response to vitamin (GO:0071295) | 3.20658997 |
| 116 | inositol phosphate catabolic process (GO:0071545) | 3.20221219 |
| 117 | calcium ion import (GO:0070509) | 3.18739498 |
| 118 | regulation of transcription involved in cell fate commitment (GO:0060850) | 3.18676768 |
| 119 | nucleoside diphosphate catabolic process (GO:0009134) | 3.18410069 |
| 120 | negative regulation of bone resorption (GO:0045779) | 3.17608083 |
| 121 | negative regulation of hormone biosynthetic process (GO:0032353) | 3.16670348 |
| 122 | negative regulation of hormone metabolic process (GO:0032351) | 3.16670348 |
| 123 | cellular response to glucagon stimulus (GO:0071377) | 3.16605776 |
| 124 | regulation of glycolytic process (GO:0006110) | 3.16435947 |
| 125 | establishment of protein localization to Golgi (GO:0072600) | 3.15277251 |
| 126 | toxin metabolic process (GO:0009404) | 3.14840380 |
| 127 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 3.12293961 |
| 128 | * nitric oxide mediated signal transduction (GO:0007263) | 3.11990076 |
| 129 | succinate metabolic process (GO:0006105) | 3.08902748 |
| 130 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 3.08427653 |
| 131 | muscle system process (GO:0003012) | 3.07863830 |
| 132 | regulation of hormone secretion (GO:0046883) | 3.07703334 |
| 133 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 3.06980213 |
| 134 | response to lipoprotein particle (GO:0055094) | 3.06751820 |
| 135 | intestinal epithelial cell development (GO:0060576) | 3.06637990 |
| 136 | polysaccharide catabolic process (GO:0000272) | 3.05370365 |
| 137 | myotube cell development (GO:0014904) | 3.05156575 |
| 138 | cardiac myofibril assembly (GO:0055003) | 3.04689945 |
| 139 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.04379372 |
| 140 | negative regulation of cell size (GO:0045792) | 3.04370994 |
| 141 | negative regulation of peptide hormone secretion (GO:0090278) | 3.03366643 |
| 142 | positive regulation of macroautophagy (GO:0016239) | 3.02428969 |
| 143 | positive regulation of protein autophosphorylation (GO:0031954) | 3.01955082 |
| 144 | cellular response to zinc ion (GO:0071294) | 3.00817645 |
| 145 | regulation of peptide transport (GO:0090087) | 3.00495453 |
| 146 | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176) | 3.00233799 |
| 147 | protein N-linked glycosylation (GO:0006487) | 2.99715335 |
| 148 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.98437619 |
| 149 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.95334720 |
| 150 | inositol phosphate dephosphorylation (GO:0046855) | 2.95334720 |
| 151 | ER to Golgi vesicle-mediated transport (GO:0006888) | 2.94760692 |
| 152 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.94699334 |
| 153 | negative regulation of peptide secretion (GO:0002792) | 2.93610808 |
| 154 | positive regulation of steroid biosynthetic process (GO:0010893) | 2.93556681 |
| 155 | negative regulation of Ras GTPase activity (GO:0034261) | 2.93372515 |
| 156 | energy reserve metabolic process (GO:0006112) | 2.93323284 |
| 157 | * peptide hormone secretion (GO:0030072) | 2.92193064 |
| 158 | ganglion development (GO:0061548) | 2.91860490 |
| 159 | endoplasmic reticulum organization (GO:0007029) | 2.91325782 |
| 160 | * peptide secretion (GO:0002790) | 2.90173163 |
| 161 | gluconeogenesis (GO:0006094) | 2.89933728 |
| 162 | response to activity (GO:0014823) | 2.89627039 |
| 163 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.89220425 |
| 164 | nodal signaling pathway (GO:0038092) | 2.85338499 |
| 165 | negative regulation of GTP catabolic process (GO:0033125) | 2.85074420 |
| 166 | negative regulation of GTPase activity (GO:0034260) | 2.85074420 |
| 167 | regulation of norepinephrine secretion (GO:0014061) | 2.84542590 |
| 168 | induction of positive chemotaxis (GO:0050930) | 2.83591919 |
| 169 | response to inactivity (GO:0014854) | 2.82435475 |
| 170 | activation of protein kinase B activity (GO:0032148) | 2.81939074 |
| 171 | * response to glucose (GO:0009749) | 2.81733566 |
| 172 | regulation of gluconeogenesis (GO:0006111) | 2.81543659 |
| 173 | positive regulation of hormone secretion (GO:0046887) | 2.81321219 |
| 174 | * response to hexose (GO:0009746) | 2.80744901 |
| 175 | negative regulation of glycogen metabolic process (GO:0070874) | 2.79781064 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 8.30530056 |
| 2 | GATA1_22025678_ChIP-Seq_K562_Human | 5.28029246 |
| 3 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.90960088 |
| 4 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.88777686 |
| 5 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.70676245 |
| 6 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 2.48576447 |
| 7 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 2.26290178 |
| 8 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.23524109 |
| 9 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.20285972 |
| 10 | HTT_18923047_ChIP-ChIP_STHdh_Human | 2.04071601 |
| 11 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.99628033 |
| 12 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.99419259 |
| 13 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.98868761 |
| 14 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.91866980 |
| 15 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.90655976 |
| 16 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.90420243 |
| 17 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.88388316 |
| 18 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.86870366 |
| 19 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.84008615 |
| 20 | GATA1_19941826_ChIP-Seq_K562_Human | 1.83857028 |
| 21 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.79172892 |
| 22 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.75413321 |
| 23 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.73270597 |
| 24 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.69594499 |
| 25 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.69304869 |
| 26 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.65669079 |
| 27 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.64814235 |
| 28 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.64785102 |
| 29 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.60753108 |
| 30 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.59626388 |
| 31 | * TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.59598991 |
| 32 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.56853090 |
| 33 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.52826318 |
| 34 | KDM2B_26808549_Chip-Seq_K562_Human | 1.52584889 |
| 35 | * RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.52555409 |
| 36 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.51465684 |
| 37 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.49815665 |
| 38 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.49510569 |
| 39 | * EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.48281176 |
| 40 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.47470342 |
| 41 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.45796186 |
| 42 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.42249039 |
| 43 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.40450562 |
| 44 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.40314438 |
| 45 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.40155339 |
| 46 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.37746180 |
| 47 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.37637341 |
| 48 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.34638577 |
| 49 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.34060271 |
| 50 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.32432831 |
| 51 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.31771818 |
| 52 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.31717864 |
| 53 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.30989617 |
| 54 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.29861014 |
| 55 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.27553238 |
| 56 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.26119817 |
| 57 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.26098910 |
| 58 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.25316581 |
| 59 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.23756344 |
| 60 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.22582786 |
| 61 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.22207644 |
| 62 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.20712056 |
| 63 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.18385822 |
| 64 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.17600912 |
| 65 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.17524574 |
| 66 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.16556287 |
| 67 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.15890813 |
| 68 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.14959781 |
| 69 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.13441243 |
| 70 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.13279106 |
| 71 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.12569272 |
| 72 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.12528776 |
| 73 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.12501635 |
| 74 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.12252507 |
| 75 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.12083415 |
| 76 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.11969643 |
| 77 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.11891691 |
| 78 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.11812806 |
| 79 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.11630590 |
| 80 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.10896455 |
| 81 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.10779633 |
| 82 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.09214104 |
| 83 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.09170112 |
| 84 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09165974 |
| 85 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.08949477 |
| 86 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.08442582 |
| 87 | CBP_21632823_ChIP-Seq_H3396_Human | 1.08086234 |
| 88 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.07529474 |
| 89 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06561204 |
| 90 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.06458852 |
| 91 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.06083941 |
| 92 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.05770560 |
| 93 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.05081745 |
| 94 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.05081745 |
| 95 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.03562347 |
| 96 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.03525476 |
| 97 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.03452764 |
| 98 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.03436286 |
| 99 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.03025665 |
| 100 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.02865411 |
| 101 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.02147030 |
| 102 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.01878953 |
| 103 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.01213236 |
| 104 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00471686 |
| 105 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.99861428 |
| 106 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.99791052 |
| 107 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.97778340 |
| 108 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.97270820 |
| 109 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.97047888 |
| 110 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.96355296 |
| 111 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96309258 |
| 112 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.95773424 |
| 113 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95691662 |
| 114 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.95493186 |
| 115 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94653004 |
| 116 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.94575615 |
| 117 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.91488977 |
| 118 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.91005313 |
| 119 | SPI1_23127762_ChIP-Seq_K562_Human | 0.90800631 |
| 120 | STAT3_23295773_ChIP-Seq_U87_Human | 0.90746001 |
| 121 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.90493222 |
| 122 | * AR_19668381_ChIP-Seq_PC3_Human | 0.90456896 |
| 123 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.90264668 |
| 124 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.90071622 |
| 125 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.89988513 |
| 126 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.88820138 |
| 127 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.88638103 |
| 128 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.88346592 |
| 129 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.87945932 |
| 130 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.87219527 |
| 131 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.87174780 |
| 132 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.86982423 |
| 133 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.86570658 |
| 134 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.86489023 |
| 135 | * EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.86389441 |
| 136 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.86276848 |
| 137 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.85978302 |
| 138 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.85557377 |
| 139 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.85359405 |
| 140 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.85333144 |
| 141 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.84852986 |
| 142 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.84562559 |
| 143 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.84561280 |
| 144 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.83921707 |
| 145 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.83280686 |
| 146 | NFYB_21822215_ChIP-Seq_K562_Human | 0.82999550 |
| 147 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.82981157 |
| 148 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.82784049 |
| 149 | * TP53_22573176_ChIP-Seq_HFKS_Human | 0.82022893 |
| 150 | TBL1_22424771_ChIP-Seq_293T_Human | 0.80749731 |
| 151 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.80457645 |
| 152 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.80457645 |
| 153 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.80290733 |
| 154 | SETDB1_19884257_ChIP-Seq_MESCs_Mouse | 0.78806417 |
| 155 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.76056662 |
| 156 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.75236131 |
| 157 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.75236131 |
| 158 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.74782655 |
| 159 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.73928519 |
| 160 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.73521994 |
| 161 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.72296528 |
| 162 | LDB1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.72204414 |
| 163 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.71776640 |
| 164 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.71774937 |
| 165 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.71650947 |
| 166 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.70965420 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003283_abnormal_digestive_organ | 6.34092112 |
| 2 | MP0002877_abnormal_melanocyte_morpholog | 5.54648739 |
| 3 | MP0002909_abnormal_adrenal_gland | 4.94414869 |
| 4 | * MP0002693_abnormal_pancreas_physiology | 4.41929560 |
| 5 | MP0009780_abnormal_chondrocyte_physiolo | 3.96098435 |
| 6 | MP0003195_calcinosis | 3.85575744 |
| 7 | * MP0001944_abnormal_pancreas_morphology | 3.68660856 |
| 8 | MP0000678_abnormal_parathyroid_gland | 3.65996873 |
| 9 | MP0003646_muscle_fatigue | 3.55137353 |
| 10 | MP0004043_abnormal_pH_regulation | 3.34883789 |
| 11 | MP0000013_abnormal_adipose_tissue | 2.90832764 |
| 12 | MP0005451_abnormal_body_composition | 2.88896352 |
| 13 | MP0000751_myopathy | 2.83327114 |
| 14 | MP0005379_endocrine/exocrine_gland_phen | 2.81737548 |
| 15 | MP0002234_abnormal_pharynx_morphology | 2.52886563 |
| 16 | MP0004145_abnormal_muscle_electrophysio | 2.45702522 |
| 17 | MP0002106_abnormal_muscle_physiology | 2.36682021 |
| 18 | * MP0002078_abnormal_glucose_homeostasis | 2.34530786 |
| 19 | MP0001986_abnormal_taste_sensitivity | 2.31880882 |
| 20 | MP0006036_abnormal_mitochondrial_physio | 2.22982770 |
| 21 | MP0005220_abnormal_exocrine_pancreas | 2.21267192 |
| 22 | MP0004087_abnormal_muscle_fiber | 2.19319928 |
| 23 | MP0003300_gastrointestinal_ulcer | 2.11001296 |
| 24 | MP0005330_cardiomyopathy | 2.09267347 |
| 25 | MP0002896_abnormal_bone_mineralization | 1.94036208 |
| 26 | MP0008961_abnormal_basal_metabolism | 1.89597062 |
| 27 | MP0002837_dystrophic_cardiac_calcinosis | 1.86450540 |
| 28 | MP0004264_abnormal_extraembryonic_tissu | 1.83373263 |
| 29 | MP0002822_catalepsy | 1.82378754 |
| 30 | MP0003183_abnormal_peptide_metabolism | 1.80384039 |
| 31 | MP0002163_abnormal_gland_morphology | 1.79887847 |
| 32 | MP0003172_abnormal_lysosome_physiology | 1.79342771 |
| 33 | MP0002108_abnormal_muscle_morphology | 1.78722364 |
| 34 | MP0000750_abnormal_muscle_regeneration | 1.78258170 |
| 35 | MP0010386_abnormal_urinary_bladder | 1.77835378 |
| 36 | MP0004270_analgesia | 1.76308316 |
| 37 | MP0005620_abnormal_muscle_contractility | 1.73227122 |
| 38 | MP0000003_abnormal_adipose_tissue | 1.71204690 |
| 39 | MP0000462_abnormal_digestive_system | 1.70012551 |
| 40 | MP0002332_abnormal_exercise_endurance | 1.69750515 |
| 41 | MP0003806_abnormal_nucleotide_metabolis | 1.63090220 |
| 42 | MP0003045_fibrosis | 1.56425239 |
| 43 | MP0004036_abnormal_muscle_relaxation | 1.50986064 |
| 44 | MP0003122_maternal_imprinting | 1.47789526 |
| 45 | MP0003252_abnormal_bile_duct | 1.46960638 |
| 46 | MP0002928_abnormal_bile_duct | 1.46555045 |
| 47 | MP0003868_abnormal_feces_composition | 1.45726725 |
| 48 | MP0001661_extended_life_span | 1.45500055 |
| 49 | MP0001765_abnormal_ion_homeostasis | 1.44900853 |
| 50 | MP0005266_abnormal_metabolism | 1.38025782 |
| 51 | MP0008004_abnormal_stomach_pH | 1.37636635 |
| 52 | MP0005187_abnormal_penis_morphology | 1.33866763 |
| 53 | MP0000733_abnormal_muscle_development | 1.29747048 |
| 54 | * MP0003953_abnormal_hormone_level | 1.28781022 |
| 55 | MP0000613_abnormal_salivary_gland | 1.27172216 |
| 56 | MP0003119_abnormal_digestive_system | 1.26489912 |
| 57 | MP0005076_abnormal_cell_differentiation | 1.23631709 |
| 58 | MP0003959_abnormal_lean_body | 1.23465307 |
| 59 | MP0001270_distended_abdomen | 1.20362844 |
| 60 | MP0006054_spinal_hemorrhage | 1.17679761 |
| 61 | MP0002638_abnormal_pupillary_reflex | 1.12029192 |
| 62 | MP0002269_muscular_atrophy | 1.10392436 |
| 63 | MP0002972_abnormal_cardiac_muscle | 1.09906094 |
| 64 | MP0005646_abnormal_pituitary_gland | 1.09904439 |
| 65 | MP0006072_abnormal_retinal_apoptosis | 1.07969982 |
| 66 | MP0002971_abnormal_brown_adipose | 1.07348913 |
| 67 | MP0008877_abnormal_DNA_methylation | 1.06895241 |
| 68 | MP0002876_abnormal_thyroid_physiology | 1.06736394 |
| 69 | MP0004215_abnormal_myocardial_fiber | 1.06224786 |
| 70 | MP0005645_abnormal_hypothalamus_physiol | 1.05826541 |
| 71 | MP0002127_abnormal_cardiovascular_syste | 1.04280751 |
| 72 | MP0004858_abnormal_nervous_system | 1.04185206 |
| 73 | MP0000747_muscle_weakness | 1.03910888 |
| 74 | MP0002277_abnormal_respiratory_mucosa | 1.03523607 |
| 75 | MP0004185_abnormal_adipocyte_glucose | 1.02027826 |
| 76 | MP0005375_adipose_tissue_phenotype | 1.00908445 |
| 77 | MP0001299_abnormal_eye_distance/ | 0.99818028 |
| 78 | MP0005058_abnormal_lysosome_morphology | 0.99597133 |
| 79 | MP0005535_abnormal_body_temperature | 0.98206924 |
| 80 | MP0000428_abnormal_craniofacial_morphol | 0.95521193 |
| 81 | MP0003866_abnormal_defecation | 0.95396493 |
| 82 | MP0000631_abnormal_neuroendocrine_gland | 0.93350075 |
| 83 | MP0009840_abnormal_foam_cell | 0.91365780 |
| 84 | MP0009046_muscle_twitch | 0.89402936 |
| 85 | MP0010234_abnormal_vibrissa_follicle | 0.88394395 |
| 86 | MP0005365_abnormal_bile_salt | 0.88154560 |
| 87 | MP0009672_abnormal_birth_weight | 0.87742196 |
| 88 | MP0003121_genomic_imprinting | 0.87617709 |
| 89 | MP0004084_abnormal_cardiac_muscle | 0.86666469 |
| 90 | MP0005257_abnormal_intraocular_pressure | 0.85612043 |
| 91 | MP0005332_abnormal_amino_acid | 0.83313781 |
| 92 | MP0001666_abnormal_nutrient_absorption | 0.81210883 |
| 93 | MP0005083_abnormal_biliary_tract | 0.81182699 |
| 94 | MP0002168_other_aberrant_phenotype | 0.80785295 |
| 95 | MP0000639_abnormal_adrenal_gland | 0.78311879 |
| 96 | MP0003787_abnormal_imprinting | 0.77752922 |
| 97 | MP0004510_myositis | 0.77661373 |
| 98 | * MP0009643_abnormal_urine_homeostasis | 0.77156733 |
| 99 | MP0000230_abnormal_systemic_arterial | 0.76752138 |
| 100 | MP0010630_abnormal_cardiac_muscle | 0.76064350 |
| 101 | MP0005448_abnormal_energy_balance | 0.75978522 |
| 102 | MP0002160_abnormal_reproductive_system | 0.74785941 |
| 103 | MP0005310_abnormal_salivary_gland | 0.74498252 |
| 104 | MP0004484_altered_response_of | 0.73929543 |
| 105 | MP0005670_abnormal_white_adipose | 0.73472528 |
| 106 | MP0001727_abnormal_embryo_implantation | 0.72261998 |
| 107 | MP0000749_muscle_degeneration | 0.71429159 |
| 108 | MP0001849_ear_inflammation | 0.70742682 |
| 109 | MP0002090_abnormal_vision | 0.70604167 |
| 110 | MP0005452_abnormal_adipose_tissue | 0.70403174 |
| 111 | MP0009703_decreased_birth_body | 0.70008327 |
| 112 | MP0000516_abnormal_urinary_system | 0.69755983 |
| 113 | MP0005367_renal/urinary_system_phenotyp | 0.69755983 |
| 114 | MP0001756_abnormal_urination | 0.69404495 |
| 115 | MP0000955_abnormal_spinal_cord | 0.66548813 |
| 116 | MP0000470_abnormal_stomach_morphology | 0.62742213 |
| 117 | MP0005636_abnormal_mineral_homeostasis | 0.61237382 |
| 118 | MP0005248_abnormal_Harderian_gland | 0.59515188 |
| 119 | MP0001984_abnormal_olfaction | 0.57259443 |
| 120 | MP0004130_abnormal_muscle_cell | 0.56639445 |
| 121 | MP0005334_abnormal_fat_pad | 0.56400851 |
| 122 | MP0001348_abnormal_lacrimal_gland | 0.56361056 |
| 123 | MP0003566_abnormal_cell_adhesion | 0.55206792 |
| 124 | MP0002069_abnormal_eating/drinking_beha | 0.54632250 |
| 125 | MP0000759_abnormal_skeletal_muscle | 0.54334132 |
| 126 | MP0002177_abnormal_outer_ear | 0.54176250 |
| 127 | MP0004085_abnormal_heartbeat | 0.53961676 |
| 128 | MP0002733_abnormal_thermal_nociception | 0.53535459 |
| 129 | MP0003879_abnormal_hair_cell | 0.53493931 |
| 130 | MP0003329_amyloid_beta_deposits | 0.53212243 |
| 131 | MP0004233_abnormal_muscle_weight | 0.52495370 |
| 132 | MP0003123_paternal_imprinting | 0.51793896 |
| 133 | MP0002118_abnormal_lipid_homeostasis | 0.50230754 |
| 134 | MP0005666_abnormal_adipose_tissue | 0.49801756 |
| 135 | MP0002138_abnormal_hepatobiliary_system | 0.48864743 |
| 136 | MP0003705_abnormal_hypodermis_morpholog | 0.48703848 |
| 137 | MP0001502_abnormal_circadian_rhythm | 0.48357124 |
| 138 | MP0000681_abnormal_thyroid_gland | 0.47597155 |
| 139 | MP0005369_muscle_phenotype | 0.46731683 |
| 140 | MP0003633_abnormal_nervous_system | 0.46711725 |
| 141 | MP0004134_abnormal_chest_morphology | 0.46562937 |
| 142 | MP0010678_abnormal_skin_adnexa | 0.46332848 |
| 143 | * MP0009642_abnormal_blood_homeostasis | 0.46311231 |
| 144 | MP0005385_cardiovascular_system_phenoty | 0.44764723 |
| 145 | MP0001544_abnormal_cardiovascular_syste | 0.44764723 |
| 146 | MP0005319_abnormal_enzyme/_coenzyme | 0.44324012 |
| 147 | MP0002970_abnormal_white_adipose | 0.43460277 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperinsulinemic hypoglycemia (HP:0000825) | 8.65599995 |
| 2 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 7.05092891 |
| 3 | Hypoglycemic seizures (HP:0002173) | 7.00408691 |
| 4 | Muscle fiber inclusion bodies (HP:0100299) | 6.88227489 |
| 5 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 6.62768641 |
| 6 | Insulin-resistant diabetes mellitus (HP:0000831) | 6.41288504 |
| 7 | Nemaline bodies (HP:0003798) | 6.38632711 |
| 8 | Pancreatic islet-cell hyperplasia (HP:0004510) | 6.33135624 |
| 9 | Symptomatic seizures (HP:0011145) | 6.11219196 |
| 10 | Hypoglycemic coma (HP:0001325) | 5.98812694 |
| 11 | Abnormality of endocrine pancreas physiology (HP:0012093) | 5.74398403 |
| 12 | Abnormality of the pancreatic islet cells (HP:0006476) | 5.74398403 |
| 13 | Large for gestational age (HP:0001520) | 5.65297796 |
| 14 | Hyperglycemia (HP:0003074) | 5.41809685 |
| 15 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.24509435 |
| 16 | Calf muscle hypertrophy (HP:0008981) | 5.02291599 |
| 17 | Exercise-induced muscle cramps (HP:0003710) | 4.94601649 |
| 18 | Ketoacidosis (HP:0001993) | 4.76410320 |
| 19 | Type 1 muscle fiber predominance (HP:0003803) | 4.40768262 |
| 20 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 4.28827516 |
| 21 | EMG: myopathic abnormalities (HP:0003458) | 4.25051892 |
| 22 | Late onset (HP:0003584) | 4.19464090 |
| 23 | Distal arthrogryposis (HP:0005684) | 4.16419606 |
| 24 | Unilateral renal agenesis (HP:0000122) | 4.12054781 |
| 25 | Myopathic facies (HP:0002058) | 3.99173109 |
| 26 | Abnormality of the calf musculature (HP:0001430) | 3.87274597 |
| 27 | Mucopolysacchariduria (HP:0008155) | 3.72010750 |
| 28 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.72010750 |
| 29 | Abnormal pancreas size (HP:0012094) | 3.62131099 |
| 30 | Hyporeflexia of lower limbs (HP:0002600) | 3.61942810 |
| 31 | Papilledema (HP:0001085) | 3.58744364 |
| 32 | Insulin resistance (HP:0000855) | 3.51652323 |
| 33 | Hypokalemia (HP:0002900) | 3.48223447 |
| 34 | Decreased circulating renin level (HP:0003351) | 3.45746012 |
| 35 | Prominent metopic ridge (HP:0005487) | 3.41597799 |
| 36 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.39603721 |
| 37 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.39603721 |
| 38 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.39603721 |
| 39 | Round ear (HP:0100830) | 3.38117492 |
| 40 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.28073156 |
| 41 | Rhabdomyolysis (HP:0003201) | 3.25367279 |
| 42 | Rimmed vacuoles (HP:0003805) | 3.24775162 |
| 43 | Difficulty running (HP:0009046) | 3.22738731 |
| 44 | Frequent falls (HP:0002359) | 3.17663261 |
| 45 | Dysostosis multiplex (HP:0000943) | 3.10266915 |
| 46 | Hyperparathyroidism (HP:0000843) | 3.08040667 |
| 47 | Abnormality of the metopic suture (HP:0005556) | 2.93766981 |
| 48 | Conjugated hyperbilirubinemia (HP:0002908) | 2.84291196 |
| 49 | Neck muscle weakness (HP:0000467) | 2.80165756 |
| 50 | Abnormality of potassium homeostasis (HP:0011042) | 2.78866291 |
| 51 | Agitation (HP:0000713) | 2.72519007 |
| 52 | Hypsarrhythmia (HP:0002521) | 2.70850050 |
| 53 | Retinal atrophy (HP:0001105) | 2.69165712 |
| 54 | Malignant hyperthermia (HP:0002047) | 2.68129948 |
| 55 | Abnormality of renin-angiotensin system (HP:0000847) | 2.67458475 |
| 56 | Subaortic stenosis (HP:0001682) | 2.66963328 |
| 57 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.66963328 |
| 58 | EEG with generalized epileptiform discharges (HP:0011198) | 2.66448401 |
| 59 | Congenital malformation of the right heart (HP:0011723) | 2.65288954 |
| 60 | Double outlet right ventricle (HP:0001719) | 2.65288954 |
| 61 | Ulnar deviation of the wrist (HP:0003049) | 2.62367294 |
| 62 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.62213306 |
| 63 | Ketosis (HP:0001946) | 2.57694504 |
| 64 | Increased circulating renin level (HP:0000848) | 2.55335439 |
| 65 | Muscle fiber splitting (HP:0003555) | 2.53995105 |
| 66 | Epileptiform EEG discharges (HP:0011182) | 2.53602834 |
| 67 | Osteomalacia (HP:0002749) | 2.52318866 |
| 68 | Hyperthyroidism (HP:0000836) | 2.52202116 |
| 69 | Hypomagnesemia (HP:0002917) | 2.47118999 |
| 70 | Hyperphosphatemia (HP:0002905) | 2.45832681 |
| 71 | Type I diabetes mellitus (HP:0100651) | 2.45315894 |
| 72 | Hypercortisolism (HP:0001578) | 2.43410980 |
| 73 | Abnormality of the intrinsic pathway (HP:0010989) | 2.43136555 |
| 74 | Hyperkalemia (HP:0002153) | 2.38622099 |
| 75 | Proximal amyotrophy (HP:0007126) | 2.35327536 |
| 76 | Missing ribs (HP:0000921) | 2.34510234 |
| 77 | Exocrine pancreatic insufficiency (HP:0001738) | 2.32585974 |
| 78 | Sudden death (HP:0001699) | 2.31445926 |
| 79 | Calcaneovalgus deformity (HP:0001848) | 2.30715199 |
| 80 | Skin nodule (HP:0200036) | 2.30665407 |
| 81 | Generalized aminoaciduria (HP:0002909) | 2.27790742 |
| 82 | Increased variability in muscle fiber diameter (HP:0003557) | 2.26787637 |
| 83 | Fetal akinesia sequence (HP:0001989) | 2.26073035 |
| 84 | Thoracolumbar scoliosis (HP:0002944) | 2.23507204 |
| 85 | Muscle stiffness (HP:0003552) | 2.19665322 |
| 86 | Scapular winging (HP:0003691) | 2.19585295 |
| 87 | Enlarged penis (HP:0000040) | 2.18524963 |
| 88 | Failure to thrive in infancy (HP:0001531) | 2.16938961 |
| 89 | Severe short stature (HP:0003510) | 2.14919249 |
| 90 | Global brain atrophy (HP:0002283) | 2.12595535 |
| 91 | Asymmetric septal hypertrophy (HP:0001670) | 2.11835844 |
| 92 | Bulbar palsy (HP:0001283) | 2.09449310 |
| 93 | Absent phalangeal crease (HP:0006109) | 2.09354112 |
| 94 | Abnormality of magnesium homeostasis (HP:0004921) | 2.07912284 |
| 95 | Congenital glaucoma (HP:0001087) | 2.06555502 |
| 96 | Limb-girdle muscle atrophy (HP:0003797) | 2.05045354 |
| 97 | Abdominal distention (HP:0003270) | 2.04038897 |
| 98 | Progressive muscle weakness (HP:0003323) | 2.03472949 |
| 99 | Downturned corners of mouth (HP:0002714) | 2.01377001 |
| 100 | Hypophosphatemia (HP:0002148) | 1.99468839 |
| 101 | Distal lower limb muscle weakness (HP:0009053) | 1.97995851 |
| 102 | Areflexia of lower limbs (HP:0002522) | 1.96876290 |
| 103 | Visual hallucinations (HP:0002367) | 1.96429164 |
| 104 | Macroorchidism (HP:0000053) | 1.96137361 |
| 105 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.94806213 |
| 106 | Deformed tarsal bones (HP:0008119) | 1.94023418 |
| 107 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.92764637 |
| 108 | Muscular dystrophy (HP:0003560) | 1.89444635 |
| 109 | Abnormality of the common coagulation pathway (HP:0010990) | 1.86468670 |
| 110 | Hypotension (HP:0002615) | 1.84529003 |
| 111 | Hepatic necrosis (HP:0002605) | 1.83474427 |
| 112 | Stridor (HP:0010307) | 1.83042772 |
| 113 | EMG: neuropathic changes (HP:0003445) | 1.82353759 |
| 114 | Myoglobinuria (HP:0002913) | 1.79701831 |
| 115 | Sex reversal (HP:0012245) | 1.79305944 |
| 116 | Abnormal sex determination (HP:0012244) | 1.79305944 |
| 117 | Hypokinesia (HP:0002375) | 1.77492683 |
| 118 | Protuberant abdomen (HP:0001538) | 1.76324213 |
| 119 | Dilated cardiomyopathy (HP:0001644) | 1.74547749 |
| 120 | Restlessness (HP:0000711) | 1.73187622 |
| 121 | Fatigable weakness (HP:0003473) | 1.72777735 |
| 122 | Abnormality of the neuromuscular junction (HP:0003398) | 1.72777735 |
| 123 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.71019725 |
| 124 | Villous atrophy (HP:0011473) | 1.71019725 |
| 125 | Hypothermia (HP:0002045) | 1.69821279 |
| 126 | Dysautonomia (HP:0002459) | 1.69280567 |
| 127 | Postural tremor (HP:0002174) | 1.68617969 |
| 128 | Exercise-induced myalgia (HP:0003738) | 1.68052365 |
| 129 | Pheochromocytoma (HP:0002666) | 1.67640798 |
| 130 | Bundle branch block (HP:0011710) | 1.67267265 |
| 131 | Generalized muscle weakness (HP:0003324) | 1.67242165 |
| 132 | Limb hypertonia (HP:0002509) | 1.67144749 |
| 133 | Abnormal finger flexion creases (HP:0006143) | 1.66955227 |
| 134 | Hyperphosphaturia (HP:0003109) | 1.65795586 |
| 135 | Cerebral inclusion bodies (HP:0100314) | 1.65117067 |
| 136 | Turricephaly (HP:0000262) | 1.64609471 |
| 137 | Bronchomalacia (HP:0002780) | 1.63751473 |
| 138 | Back pain (HP:0003418) | 1.63454030 |
| 139 | Weak cry (HP:0001612) | 1.63073447 |
| 140 | Tongue fasciculations (HP:0001308) | 1.62907002 |
| 141 | Cerebral aneurysm (HP:0004944) | 1.62771577 |
| 142 | Hyperactive renin-angiotensin system (HP:0000841) | 1.62619460 |
| 143 | Cortical visual impairment (HP:0100704) | 1.61197366 |
| 144 | Menstrual irregularities (HP:0000858) | 1.61150894 |
| 145 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.59797334 |
| 146 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.59797334 |
| 147 | Glucose intolerance (HP:0000833) | 1.59665770 |
| 148 | Thin bony cortex (HP:0002753) | 1.59410415 |
| 149 | Difficulty climbing stairs (HP:0003551) | 1.58815172 |
| 150 | Ventricular fibrillation (HP:0001663) | 1.58708309 |
| 151 | Shoulder girdle muscle weakness (HP:0003547) | 1.58224564 |
| 152 | Elevated alkaline phosphatase (HP:0003155) | 1.58164139 |
| 153 | Testicular neoplasm (HP:0010788) | 1.57937289 |
| 154 | Gowers sign (HP:0003391) | 1.57144491 |
| 155 | Adrenal overactivity (HP:0002717) | 1.54713469 |
| 156 | Muscle fibrillation (HP:0010546) | 1.53190011 |
| 157 | Tetany (HP:0001281) | 1.52834629 |
| 158 | Muscular hypotonia of the trunk (HP:0008936) | 1.51028776 |
| 159 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.48996588 |
| 160 | Ankyloglossia (HP:0010296) | 1.48201856 |
| 161 | Generalized hyperpigmentation (HP:0007440) | 1.48022868 |
| 162 | Progressive neurologic deterioration (HP:0002344) | 1.46936145 |
| 163 | Insomnia (HP:0100785) | 1.46700527 |
| 164 | Resting tremor (HP:0002322) | 1.45264672 |
| 165 | Intrahepatic cholestasis (HP:0001406) | 1.44973970 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 8.09685786 |
| 2 | INSRR | 7.42113059 |
| 3 | PASK | 5.89028090 |
| 4 | TAOK3 | 5.15592497 |
| 5 | PINK1 | 4.32841442 |
| 6 | HIPK2 | 3.32579061 |
| 7 | TTN | 2.90631019 |
| 8 | PRKD3 | 2.84648470 |
| 9 | MAP3K2 | 2.69189503 |
| 10 | MAPK15 | 2.60365596 |
| 11 | TRIB3 | 2.49933493 |
| 12 | SCYL2 | 2.29462906 |
| 13 | PDGFRA | 2.24854293 |
| 14 | FGFR2 | 2.20041754 |
| 15 | ERN1 | 2.19828867 |
| 16 | FRK | 1.93003715 |
| 17 | UHMK1 | 1.90699261 |
| 18 | MUSK | 1.86940659 |
| 19 | PRKCH | 1.74057124 |
| 20 | PTK6 | 1.70781852 |
| 21 | NTRK3 | 1.69113599 |
| 22 | SIK1 | 1.64783718 |
| 23 | DAPK2 | 1.60186905 |
| 24 | TRPM7 | 1.54711929 |
| 25 | FLT3 | 1.53845831 |
| 26 | NTRK1 | 1.53425672 |
| 27 | CAMKK2 | 1.45455402 |
| 28 | IRAK3 | 1.45325609 |
| 29 | MAP3K9 | 1.36301079 |
| 30 | CDC42BPA | 1.34582570 |
| 31 | WNK4 | 1.32403159 |
| 32 | STK16 | 1.26813736 |
| 33 | PTK2 | 1.24539040 |
| 34 | MAP2K6 | 1.23720836 |
| 35 | PRKD2 | 1.22855004 |
| 36 | DYRK1B | 1.17205319 |
| 37 | MAP3K7 | 1.15039819 |
| 38 | BRSK2 | 1.14924759 |
| 39 | STK38L | 1.13303209 |
| 40 | NME1 | 1.09895202 |
| 41 | RET | 1.05757570 |
| 42 | ALK | 1.02016271 |
| 43 | JAK2 | 0.98776521 |
| 44 | KSR2 | 0.97715005 |
| 45 | MAPK12 | 0.95152503 |
| 46 | MAP3K10 | 0.95077210 |
| 47 | EPHA3 | 0.93550474 |
| 48 | LATS1 | 0.89233051 |
| 49 | PKN2 | 0.88134839 |
| 50 | PRKAA1 | 0.86558607 |
| 51 | ICK | 0.84857155 |
| 52 | MET | 0.84439715 |
| 53 | CSNK1G1 | 0.83631335 |
| 54 | MAPKAPK3 | 0.81586490 |
| 55 | LMTK2 | 0.81233112 |
| 56 | MARK3 | 0.77332440 |
| 57 | JAK1 | 0.75743335 |
| 58 | CAMKK1 | 0.74341476 |
| 59 | MARK2 | 0.73746958 |
| 60 | PRKD1 | 0.70673307 |
| 61 | EEF2K | 0.69355515 |
| 62 | WNK1 | 0.68856275 |
| 63 | CSNK1G3 | 0.68746298 |
| 64 | CAMK2G | 0.66240672 |
| 65 | PAK3 | 0.65945360 |
| 66 | RIPK1 | 0.65271805 |
| 67 | PDGFRB | 0.63588002 |
| 68 | CAMK1G | 0.61807808 |
| 69 | IRAK2 | 0.61200993 |
| 70 | FER | 0.61131090 |
| 71 | IRAK1 | 0.61045873 |
| 72 | AKT2 | 0.61005587 |
| 73 | MTOR | 0.60884544 |
| 74 | LATS2 | 0.59360930 |
| 75 | SGK2 | 0.58543585 |
| 76 | MAP2K2 | 0.58311612 |
| 77 | NLK | 0.58301819 |
| 78 | NME2 | 0.57243537 |
| 79 | STK3 | 0.56815933 |
| 80 | CAMK2D | 0.52548984 |
| 81 | MAPK11 | 0.51898246 |
| 82 | * MAP3K1 | 0.51890361 |
| 83 | ITK | 0.51439135 |
| 84 | GSK3A | 0.50812124 |
| 85 | CSNK1G2 | 0.48015768 |
| 86 | MOS | 0.47887321 |
| 87 | FGFR3 | 0.46786519 |
| 88 | FGFR4 | 0.46739341 |
| 89 | PRKACG | 0.46502814 |
| 90 | MAP2K4 | 0.46327655 |
| 91 | CDK12 | 0.45567638 |
| 92 | PRKG2 | 0.44566515 |
| 93 | ROCK1 | 0.44361533 |
| 94 | MAP2K7 | 0.43892464 |
| 95 | CCNB1 | 0.42967961 |
| 96 | BMPR1B | 0.42583026 |
| 97 | STK24 | 0.42434645 |
| 98 | EPHB1 | 0.42375328 |
| 99 | PHKG1 | 0.41222316 |
| 100 | PHKG2 | 0.41222316 |
| 101 | DMPK | 0.40592504 |
| 102 | SGK223 | 0.40257286 |
| 103 | SGK494 | 0.40257286 |
| 104 | WNK3 | 0.39023274 |
| 105 | PRKCI | 0.36926491 |
| 106 | ADRBK1 | 0.36242986 |
| 107 | ERBB3 | 0.36063310 |
| 108 | PRKG1 | 0.35966828 |
| 109 | GRK1 | 0.35303579 |
| 110 | RPS6KA2 | 0.34769764 |
| 111 | PRKDC | 0.34534910 |
| 112 | BRSK1 | 0.34005612 |
| 113 | TAOK1 | 0.33867826 |
| 114 | STK11 | 0.33286160 |
| 115 | DAPK3 | 0.33263621 |
| 116 | CDK5 | 0.33152541 |
| 117 | CAMK1 | 0.33133708 |
| 118 | AKT3 | 0.32830532 |
| 119 | PRKCE | 0.32601221 |
| 120 | CDK3 | 0.32583823 |
| 121 | MAP3K3 | 0.32210476 |
| 122 | MAP2K3 | 0.32170821 |
| 123 | ADRBK2 | 0.32138459 |
| 124 | LIMK1 | 0.31476927 |
| 125 | GRK5 | 0.31365594 |
| 126 | IGF1R | 0.31006562 |
| 127 | PIK3CG | 0.30831577 |
| 128 | RPS6KA3 | 0.30652355 |
| 129 | PRKACA | 0.30198099 |
| 130 | CAMK2B | 0.30182209 |
| 131 | PNCK | 0.30013844 |
| 132 | MAP2K1 | 0.28972137 |
| 133 | BCKDK | 0.28616700 |
| 134 | MST4 | 0.27852778 |
| 135 | PRKCG | 0.26440106 |
| 136 | EIF2AK3 | 0.26313703 |
| 137 | ABL2 | 0.25341694 |
| 138 | CSNK1A1L | 0.24660389 |
| 139 | RPS6KB1 | 0.24657566 |
| 140 | CSNK1A1 | 0.24531153 |
| 141 | PAK6 | 0.23852484 |
| 142 | * MAPK14 | 0.23829382 |
| 143 | SGK3 | 0.23126082 |
| 144 | PDK1 | 0.22376919 |
| 145 | EGFR | 0.21206661 |
| 146 | STK4 | 0.21051675 |
| 147 | PRKCA | 0.20242865 |
| 148 | PDPK1 | 0.20182444 |
| 149 | SMG1 | 0.19740355 |
| 150 | GSK3B | 0.18790021 |
| 151 | JAK3 | 0.18644900 |
| 152 | PRKAA2 | 0.18624148 |
| 153 | CAMK2A | 0.18135997 |
| 154 | BRD4 | 0.17761394 |
| 155 | PRKCB | 0.17474890 |
| 156 | SGK1 | 0.17203645 |
| 157 | MAPK9 | 0.17162667 |
| 158 | MAPK10 | 0.17081715 |
| 159 | ROCK2 | 0.16906934 |
| 160 | CHUK | 0.16689789 |
| 161 | BRAF | 0.16487541 |
| 162 | CSNK1D | 0.15921093 |
| 163 | PRKACB | 0.15844972 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 8.46461434 |
| 2 | Insulin secretion_Homo sapiens_hsa04911 | 3.63049666 |
| 3 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 3.22581843 |
| 4 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.15230077 |
| 5 | Protein export_Homo sapiens_hsa03060 | 3.12253801 |
| 6 | * Type II diabetes mellitus_Homo sapiens_hsa04930 | 2.84750586 |
| 7 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.43911942 |
| 8 | Regulation of autophagy_Homo sapiens_hsa04140 | 2.32399833 |
| 9 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.11101526 |
| 10 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 2.05202398 |
| 11 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.76074625 |
| 12 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.69692060 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.61511958 |
| 14 | Cocaine addiction_Homo sapiens_hsa05030 | 1.61498035 |
| 15 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.60600087 |
| 16 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.49226196 |
| 17 | Insulin resistance_Homo sapiens_hsa04931 | 1.46103792 |
| 18 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.45321808 |
| 19 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.44357655 |
| 20 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.43470902 |
| 21 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.40134769 |
| 22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.35266925 |
| 23 | Lysosome_Homo sapiens_hsa04142 | 1.31911140 |
| 24 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.31380720 |
| 25 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.30156837 |
| 26 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.29882195 |
| 27 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.24174016 |
| 28 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.23768927 |
| 29 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.21882497 |
| 30 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.15012657 |
| 31 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.14125407 |
| 32 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.13883442 |
| 33 | ABC transporters_Homo sapiens_hsa02010 | 1.13573856 |
| 34 | Taste transduction_Homo sapiens_hsa04742 | 1.12858814 |
| 35 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.09449077 |
| 36 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.04774530 |
| 37 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.03567009 |
| 38 | Long-term potentiation_Homo sapiens_hsa04720 | 1.03350250 |
| 39 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.01624970 |
| 40 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.00787120 |
| 41 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.00627794 |
| 42 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.00360476 |
| 43 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.99893956 |
| 44 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.98452028 |
| 45 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.98248362 |
| 46 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.98056910 |
| 47 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.96811467 |
| 48 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.95329863 |
| 49 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.93561808 |
| 50 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.92831495 |
| 51 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.92253106 |
| 52 | Alzheimers disease_Homo sapiens_hsa05010 | 0.92012903 |
| 53 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.87201329 |
| 54 | Parkinsons disease_Homo sapiens_hsa05012 | 0.84615504 |
| 55 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.84525009 |
| 56 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.83787520 |
| 57 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.83365699 |
| 58 | GABAergic synapse_Homo sapiens_hsa04727 | 0.83179801 |
| 59 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.82574971 |
| 60 | Renin secretion_Homo sapiens_hsa04924 | 0.81608006 |
| 61 | Prion diseases_Homo sapiens_hsa05020 | 0.81294156 |
| 62 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.79795160 |
| 63 | Carbon metabolism_Homo sapiens_hsa01200 | 0.79456083 |
| 64 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.77219930 |
| 65 | Circadian entrainment_Homo sapiens_hsa04713 | 0.76551085 |
| 66 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.74973590 |
| 67 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.74436457 |
| 68 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.73595226 |
| 69 | Circadian rhythm_Homo sapiens_hsa04710 | 0.73172577 |
| 70 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.72799364 |
| 71 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.69978997 |
| 72 | Mineral absorption_Homo sapiens_hsa04978 | 0.69612899 |
| 73 | Peroxisome_Homo sapiens_hsa04146 | 0.69102321 |
| 74 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.68913401 |
| 75 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.68678351 |
| 76 | Gap junction_Homo sapiens_hsa04540 | 0.67145191 |
| 77 | Bladder cancer_Homo sapiens_hsa05219 | 0.66518402 |
| 78 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.66106006 |
| 79 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.65666880 |
| 80 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.64353924 |
| 81 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.64127413 |
| 82 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.63263609 |
| 83 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.62298761 |
| 84 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.61925880 |
| 85 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.61072115 |
| 86 | Thyroid cancer_Homo sapiens_hsa05216 | 0.60400650 |
| 87 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.59117526 |
| 88 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.58176527 |
| 89 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.57956755 |
| 90 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.57919315 |
| 91 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.56678405 |
| 92 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.54394440 |
| 93 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.53472509 |
| 94 | Melanogenesis_Homo sapiens_hsa04916 | 0.52940279 |
| 95 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.52616634 |
| 96 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.52455780 |
| 97 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.51743554 |
| 98 | Morphine addiction_Homo sapiens_hsa05032 | 0.51630541 |
| 99 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.51436110 |
| 100 | Lysine degradation_Homo sapiens_hsa00310 | 0.51287849 |
| 101 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.51142351 |
| 102 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.50890810 |
| 103 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.50104415 |
| 104 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.50094294 |
| 105 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.48916965 |
| 106 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.48816370 |
| 107 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.48330341 |
| 108 | Galactose metabolism_Homo sapiens_hsa00052 | 0.46683722 |
| 109 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.45933755 |
| 110 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.45169678 |
| 111 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.44167345 |
| 112 | Tight junction_Homo sapiens_hsa04530 | 0.43968423 |
| 113 | Purine metabolism_Homo sapiens_hsa00230 | 0.43482090 |
| 114 | Prostate cancer_Homo sapiens_hsa05215 | 0.43343657 |
| 115 | Endometrial cancer_Homo sapiens_hsa05213 | 0.42103293 |
| 116 | Glioma_Homo sapiens_hsa05214 | 0.41995657 |
| 117 | Other glycan degradation_Homo sapiens_hsa00511 | 0.41957636 |
| 118 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.41221382 |
| 119 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.40747355 |
| 120 | Sulfur relay system_Homo sapiens_hsa04122 | 0.39827230 |
| 121 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.38474922 |
| 122 | Long-term depression_Homo sapiens_hsa04730 | 0.37484793 |
| 123 | Alcoholism_Homo sapiens_hsa05034 | 0.37465812 |
| 124 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.37355661 |
| 125 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.36956997 |
| 126 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.36114026 |
| 127 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.35893005 |
| 128 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.35368886 |
| 129 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.34662538 |
| 130 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.34636155 |
| 131 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.34425466 |
| 132 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.33786805 |
| 133 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.33362556 |
| 134 | Metabolic pathways_Homo sapiens_hsa01100 | 0.33359619 |
| 135 | Bile secretion_Homo sapiens_hsa04976 | 0.32395722 |
| 136 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.31899760 |
| 137 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.31739592 |
| 138 | Adherens junction_Homo sapiens_hsa04520 | 0.31327277 |
| 139 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.30563335 |
| 140 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.28887596 |
| 141 | Salivary secretion_Homo sapiens_hsa04970 | 0.27677503 |

